BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32737302)

  • 21. Cliques for the identification of gene signatures for colorectal cancer across population.
    Pradhan MP; Nagulapalli K; Palakal MJ
    BMC Syst Biol; 2012; 6 Suppl 3(Suppl 3):S17. PubMed ID: 23282040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of differentially expressed genes and their upstream regulators in colorectal cancer.
    Liu HY; Zhang CJ
    Cancer Gene Ther; 2017 Jun; 24(6):244-250. PubMed ID: 28409560
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
    DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer.
    Qi Y; Qi H; Liu Z; He P; Li B
    J Comput Biol; 2019 Apr; 26(4):364-375. PubMed ID: 30810359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
    Pirim D
    Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of an miRNA-mRNA regulatory network in colorectal cancer with bioinformatics methods.
    Su Y; Zhang M; Zhang L; Chen S; Zhang D; Zhang X
    Anticancer Drugs; 2019 Jul; 30(6):588-595. PubMed ID: 30601194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Wu S; Wu F; Jiang Z
    Oncol Rep; 2017 Oct; 38(4):2043-2050. PubMed ID: 28902367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
    Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
    Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of key genes associated with colorectal cancer based on the transcriptional network.
    Chen G; Li H; Niu X; Li G; Han N; Li X; Li G; Liu Y; Sun G; Wang Y; Li Z; Li Q
    Pathol Oncol Res; 2015 Jul; 21(3):719-25. PubMed ID: 25613817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
    Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
    Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
    Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating MicroRNA and transcription factor co-regulatory networks in colorectal cancer.
    Wang H; Luo J; Liu C; Niu H; Wang J; Liu Q; Zhao Z; Xu H; Ding Y; Sun J; Zhang Q
    BMC Bioinformatics; 2017 Sep; 18(1):388. PubMed ID: 28865443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.